|  |  | 

India Top Headlines

DRDO’s Anti-Covid 2-DG Drug Will Reduce Recovery Time and Oxygen Dependence, Says Union Health Minister | India News

img-responsive

NEW DELHI: Defense Minister Rajnath Singh and Union Health Minister Dr. Harsh Vardhan launched on Monday the first batch of anti-Covid drug 2-deoxy-D-glucose (2-DG) developed by the Defense Research and Development Organization (DRDO).
The drug has been developed by the DRDO Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr. Reddy’s Laboratories.
DRDO President Dr. G Satheesh Reddy said that DRDO and Dr. Reddy’s lab had gone through the full tests and performed them in 30 hospitals and on a large number of patients.
The first batch of 10,000 doses of 2DG medicine would be released early next week, DRDO officials informed ANI on Friday.
The medicine comes as a powder in a sachet, which is taken by mouth by dissolving it in water. It accumulates in cells infected by the virus and prevents virus growth by stopping viral synthesis and energy production. Its selective accumulation in virus-infected cells makes this drug unique.
In the second wave of Covid-19 underway, a large number of patients are facing severe oxygen dependence and are in need of hospitalization. The drug is expected to save precious lives because of the drug’s working mechanism in infected cells. This also reduces the hospital stay of Covid-19 patients.
DRDO 2-DG’s Anti-Covid Drug Will Reduce Recovery Time And Oxygen Dependence, Says Union Health Minister
New Delhi [India], May 17 (ANI): Union Health Minister Dr. Harsh Vardhan said on Monday that recovery time from COVID-19 infection and oxygen dependence will be reduced with anti-Covid drug 2-deoxy-D-glucose (2-DG) developed by the Defense Research and Development Organization (DRDO).
While speaking at the release ceremony of the first batch of 2-DG drug, Vardhan said: “With the support of DRDO and under the leadership of Union Defense Minister Rajnath Singh, this (anti-COVID 2DG drug) can be our first research-based outcome to fight Covid-19. It will reduce recovery time and oxygen dependence. ”
“I hope this drug will serve the world and not just India in the fight against Covid-19 in the coming days,” he further said.
“We have been fighting Covid-19 for the past year and our scientists have developed the vaccine and made it available to the public. I thank and congratulate DRDO and its scientists. We have seen that under the leadership of Prime Minister Modi, DRDO has played role in the fight against COVID-19 ”, he added.
He also expressed his happiness for the Covid-19 recovery rate in the country. “Today is a special and happy day for all of us as we have seen that the number of recovered cases has exceeded the number of active cases by more than one lakh,” he added.
The medicine comes as a powder in a sachet, which is taken by mouth by dissolving it in water. It accumulates in cells infected by the virus and prevents virus growth by stopping viral synthesis and energy production. Its selective accumulation in virus-infected cells makes this drug unique. In the second wave of COVID-19 underway, a large number of patients are facing severe oxygen dependence and are in need of hospitalization. The drug is expected to save precious lives because of the drug’s working mechanism in infected cells. This also reduces the hospital stay of Covid-19 patients.

Times of India

drdos-anti-covid-2-dg-drug-will-reduce-recovery-time-and-oxygen-dependence-says-union-health-minister-india-news

ABOUT THE AUTHOR